MIS Trends 2014: Improving Visualization

Innovation is driving healthy growth in the multibillion-dollar market for minimally invasive surgical products as manufacturers develop new laparoscopic visualization systems and advanced surgical tools with robotic-like features designed to enable more complex procedures to be performed via a minimally invasive approach.

Manufacturers of minimally invasive surgical (MIS) products are developing new laparoscopic visualization systems and advanced surgical tools designed to offer some of the benefits of robotic surgery without the challenges posed by current robotic platforms. These companies are counting on such hybrid solutions to provide a technological and economic middle ground between traditional laparoscopy and robotic surgery and enable more complex procedures to be performed via a minimally invasive approach. Advances in imaging, such as three-dimensional (3D) high-definition (HD) laparoscopy systems (3D HD), fluorescence imaging, and image guidance, along with new handheld tools and energy devices designed to enhance dexterity, maneuverability, rotation, precision, and ergonomics will continue to drive growth in the multibillion-dollar MIS products market. Manufacturers are also driving growth by targeting underpenetrated and emerging markets, particularly in Asia and Latin America, and by focusing education, sales, and product development efforts on underserved clinical areas with good potential for increasing MIS adoption in gynecologic, thoracic, hepatobiliary, pancreatic, colorectal, oncologic, and bariatric surgery. (SeeAlso see "Trends In MIS, Part I: Pushing Surgical Boundaries" - Medtech Insight, 25 May, 2012..)

In part one of this two-part series, Medtech Insight covers the latest advances in laparoscopic visualization, and highlights the trends...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Asia

Industry Execs Talk Tariff Turbulence During MD&M East

 

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

India-UK Free Trade Agreement Sets Stage For Medtech Growth, But Industry Demands Safeguards

 
• By 

Announced after three years of negotiation, the FTA eliminates tariffs on 99% of Indian product types, covering nearly all trade value, and reduces tariffs on 90% of UK products. Although not yet formally signed, the deal is being positioned by the Indian government as “transformative,” with an estimated economic impact of $6.4bn for the UK alone by 2040.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Medical Devices Not The Focus Of FDA’s Plans To Step Up Foreign Inspections, Expert Says

 

The US FDA recently announced plans to carry out more unannounced inspections of foreign facilities. But those inspections will primarily target drug producers, with less attention and resources allocated to those making devices.

More from Geography

Innovative Wants Injunction Against J&J Subsidiary After $442M Antitrust Verdict

 
• By 

Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.

Prix Galien Spotlights Mental Health ‘Renaissance’ But Systemic Hurdles Persist

 

Experts at the Prix Galien UK Forum discussed the future of mental health innovation, emphasizing the important roles of digital solutions, diagnostic biomarkers and community involvement.